A comparison of the health status after percutaneous coronary intervention at a hospital with and without on-site cardiac surgical backup: A randomized trial in nonemergent patients

European Journal of Cardiovascular Prevention and Rehabilitation

Volumn 17, Issue 2, 2010, Pages 235-243

  Melberg, Tor ^a,b   Nordrehaug, Jan Erik ^b,c   Nilsen, Dennis W T ^a,b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Health status; PCI; Quality of life; Surgical backup

Indexed keywords

ANTIANGINA PECTORIS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY CARE UNIT; DISEASE CLASSIFICATION; EMERGENCY WARD; EXERCISE; FEMALE; FOLLOW UP; HEALTH STATUS; HEALTH SURVEY; HEART INFARCTION; HEART SURGERY; HOSPITAL; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OPERATING ROOM; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 77951262497     PISSN: 17418267     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3283378880     Document Type: Article

References (26)

1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339:229-234.
2. Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) registry. Circulation 2000; 102:1014-1019.
3. McGuire DK, Newby LK, Bhapkar MV, Moliterno DJ, Hochman JS, Klein WW, et al. Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes. Am Heart J 2004; 147:246-252.
4. Timmer JR, Van der Horst IC, Ottervanger JP, Henriques JP, Hoorntje JC, de Boer MJ, et al. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J 2004; 148:399-404.
5. Stranders I, Diamant M, van Gelder ER, Spruijt HJ, Twisk JW, Heine RJ, Visser FC. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 2004; 164:982-988.
6. Cao JJ, Hudson M, Jankowski M, Whitehouse F, Weaver WD. Relation of chronic and acute glycemic control on mortality in acute myocardial infarction with diabetes mellitus. Am J Cardiol 2005; 96:183-186.
7. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA,Wang Y, Havranek EP, Krumholz HM. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction. Implications for patients with and without recognized diabetes. Circulation 2005; 111:3078-3086.
8. Ishihara M, Kojima S, Sakamato T, Asada Y, Tei C, Kimura K, et al. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J 2005; 150:814-820. (Pubitemid 41396520)
9. Straumann E, Kurz DJ, Muntwyler J, Stettler I, Furrer M, Naegeli B, et al. Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention. Am Heart J 2005; 150:1000-1006.
10. Meisinger C, Hörmann A, Heier M, Kuch B, Löwel H. Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusion era. Int J Cardiol 2006; 113:229-235.
11. Schiele F, Descotes-Genon V, Seronde MF, Blonde MC, Legalery P, Meneveau N, et al. Predictive value of admission hyperglycaemia on mortality in patients with acute myocardial infarction. Diabet Med 2006; 23:1370-1376.
12. Petursson P, Herlitz J, Caidahl K, Gudbjörnsdottir S, Karlsson T, Perers E, et al. Admission glycaemia and outcome after acute coronary syndrome. Int J Cardiol 2007; 116:315-320.
13. Monteiro S, Antó nio N, Gonçalves F, Monteiro P, Freitas M, Providência L. Glycaemia at admission: the metabolic echocardiography in acute coronary syndrome patients. Eur J Cardiovasc Prev Rehabil 2009; 16:164-168.
14. Bassand J-P, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 2007; 28:1598-1660.
15. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundquist C, Crea F, Falk V, et al. Management of Acute Myocardial Infarction in patients presenting with persistent ST-segment elevation. Eur Heart J 2008; 29:2909-2945.
16. The expert committee on the diagnosis and classification of diabetes mellitus: report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26 (Suppl 1):S5-S20.
17. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endoc Metab 2002; 87:978-982.
18. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003; 78:1471-1478.
19. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendíc S, Rydén L, Malmberg K. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359:2140-2144.
20. Ceriello A. Acute hyperglycaemia: a new risk factor during myocardial infarction. Eur Heart J 2005; 26:328-331.
21. Nesto R. Diabetes, Hyperglycemia, and the cardiologist: a call to action for optimizing care. Rev Cardiovasc Med 2006; 7 (Suppl 2):S1-S2.
22. Marfella R, Siniscalchi M, Esposito K, Sellitto A, De Fanis U, Romano C, et al. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care 2003; 26:3129-3135.
23. Van den Berghe G, Wouters PJ, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the surgical intensive care unit. N Engl J Med 2001; 345:1359-1367.
24. Van den Berghe G, Woouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31:359-366.
25. Finney SJ, Zekvaeld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003; 290:2041-2047.
26. Malmberg KA, Rydén LE, Wedel H, Birkeland K, Bootsma A, Dickstein K, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 2005; 26:650-661.